GTTAC provides scientific and technical advice to the Gene Technology Regulator and the Gene Technology Ministers’ Meeting.
GTTAC provides advice on:
- gene technology, genetically modified organisms (GMOs) and genetically modified (GM) products
- applications made under the Gene Technology Act 2000
- the biosafety aspects of gene technology
- principles, guidelines and codes of practice for GMOs and GM products.
The Regulator must consult the committee on all licence applications for dealings involving intentional release of GMOs into the environment (DIR) not assessed as a limited and controlled release. They must also consult on Risk Assessment and Risk Management Plans (RARMPs) prepared for all DIR licence applications.
The Gene Technology Regulations 2001 details how the committee should make decisions, its reporting requirements and procedures for convening meetings.
Members of GTTAC
The committee has 15 members appointed by the Minister. Members include experts in relevant scientific fields (such as risk assessment, public health and ecology) and a layperson. The committee must also include a member of the Gene Technology Ethics and Community Consultative Committee (GTECCC). The regulations impose strict disclosure of interest provisions on members.
Current members (2020–2023)
- Prof John Rasko AO, Chair
- Dr Graham Bonnett
- Honorary Prof Fiona Cameron
- Associate Prof Michael Considine
- Dr Paul Downey
- Dr Tessa Gargett
- Dr Grant Logan
- Associate Prof Michael Michael
- Prof Geraldine O'Neill
- Dr Gabrielle O'Sullivan
- Dr Kelly Pearce
- Dr Jason Smythe
- Prof Jane Visvader
- Prof Calum Wilson
- Prof Paul Young
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.